Exhibit 99.1
Cytec Announces Fourth Quarter and Full Year Results;
Full Year 2006 Outlook Provided
WEST PATERSON, N.J.--(BUSINESS WIRE)--Feb. 9, 2006--Cytec
Industries Inc. (NYSE:CYT) announced today net earnings available to
common stockholders for the fourth quarter of 2005 of $18.4 million or
$0.39 per diluted share on net sales of $788 million. Included in the
quarter is a $2.6 million or $0.05 per diluted share gain related to a
favorable tax development in an international jurisdiction and
restructuring charges and integration costs of $14.1 million and $0.2
million, respectively (after-tax $10.6 million or $0.22 per diluted
share). Excluding these items, net earnings available to common
stockholders were $26.4 million or $0.56 per diluted share.
Net earnings available to common stockholders for the fourth
quarter of 2004 were $46.2 million or $1.13 per diluted share on net
sales of $451 million. This includes an after tax net gain of $17.1
million or $0.42 per diluted share related to foreign currency and
interest rate hedging transactions associated with the acquisition of
the Surface Specialties business of UCB Group which was completed on
February 28, 2005. Excluding this special item, net earnings available
to common stockholders for the fourth quarter of 2004 were $29.1 or
$0.71 per diluted share.
David Lilley, Chairman, President and Chief Executive Officer
said, "The fourth quarter presented many challenges to Cytec and the
chemical industry. Raw material and energy costs spiked early in the
quarter and our people did a good job of increasing our product
prices, passing along much of the cost increases. On the demand side,
selling volumes in heritage Cytec Specialty Chemicals were generally
flat with the year ago period with declines in North America offset by
gains in Europe and Latin America while Asia was up slightly. On a
pro-forma basis, the acquired Surface Specialties businesses selling
volumes were up year on year. Building Block Chemicals volume was down
in North America and Asia. Cytec Engineered Materials had higher
volumes in the large commercial aircraft, commercial rotorcraft and
military aircraft sectors. In light of the headwinds faced, this was a
solid performance for Cytec."
The segment results discussed below have been restated to reflect
the transfer of the specialty adhesives and urethanes product lines
from Cytec Surface Specialties to Cytec Performance Chemicals as
outlined in our press release dated January 31, 2006. A brief summary
of our reportable segments reflecting the realigned product lines is
as follows:
-- Cytec Performance Chemicals - Includes the water treatment
chemicals, mining chemicals, specialty additives and phosphine
chemicals, polymer additives, specialty adhesives and
urethanes.
-- Cytec Surface Specialties - Includes radcure resins, powder
coating resins and liquid coating resins.
-- Cytec Engineered Materials is unchanged.
-- Building Block Chemicals is unchanged.
Cytec Performance Chemicals Sales increased 21% to $221 million;
Operating Earnings decreased to $17 million
Mr. Lilley continued, "In Cytec Performance Chemicals, sales of
product lines related to the acquisition of Surface Specialties added
15% to sales. In our heritage product lines, selling prices increased
6%, selling volumes increased 1% and exchange rate changes decreased
sales 1%. The selling price increases were across all product lines
and covered most but not all of the much higher raw material and
energy costs. Volumes increased in the mining chemicals and specialty
additives and phosphine chemicals due to improving demand and new
business. Water treatment chemicals and polymer additives selling
volumes declined due to the impact on demand from the hurricanes and
continuing sluggish industrial demand in North America. For the
acquired product lines, on a pro-forma basis, volumes were essentially
flat, selling prices increased 10% and exchange rate changes decreased
sales 5%.
"The decrease in operating earnings of $2.6 million was primarily
due to the impact of higher raw material and energy costs which were
not fully offset by selling price increases as well as lower fixed
cost absorption as we ran certain of our plants at reduced levels to
bring inventory levels in-line with demand.
Cytec Surface Specialties Sales increased 450% to $351 million;
Operating Earnings increase to $14 million
"Almost all of the sales increase in Cytec Surface Specialties is
due to sales of product lines related to the acquisition of Surface
Specialties. In our heritage product lines selling prices increased
1%, exchange rate changes decreased sales 2% while volumes were down
1% principally in North America where demand remains weak, partially
offset by higher volumes in Asia-Pacific. For the acquired product
lines, on a pro-forma basis, selling volumes were up 6% due to
recovery of business, selling prices increased 6% and exchange rate
changes decreased sales 5%.
"Operating earnings increased $8.9 million primarily due to the
addition of results from the Surface Specialties product lines.
Cytec Engineered Materials Sales increase 17% to $137 million;
Operating Earnings increase to $27 million
"Cytec Engineered Materials sales volumes increased 14% and
selling prices were up 3% and the impact of exchange rate changes was
flat. The volume increases were primarily due to increased aircraft
build rates for large commercial aircraft, commercial rotorcraft and
military aircraft.
"The increase of $12.9 million in operating earnings primarily
reflects the impact of increased selling volumes, the related leverage
on costs from the higher volumes, improving manufacturing performance
and good expense controls.
Building Block Chemicals Sales decrease 9% to $79 million;
Operating loss of $4 million
"Building Block Chemicals selling volumes were down 18% and
exchange rate changes reduced sales another 1% but these declines were
partially offset by higher selling prices of 10%. Our sales of
acrylonitrile in Asia-Pacific and North America were impacted by
customers reducing their purchases caused by higher selling prices in
the regions and high inventories. The increase in acrylonitrile
selling prices was driven primarily by higher raw material costs as
producers attempted to recover costs and improve margins.
"As a result of the lower demand, the acrylonitrile plant ran at
less than capacity for part of the quarter. Selling prices were not
able to catch up to the raw material and energy cost increases
experienced in the quarter as propylene and natural gas increased 23%
and 35%, respectively, versus the same period of last year. In
addition, the operating loss reflects the impact from repairs of
damage from the hurricanes of about $1.1 million with some minor work
still to be completed in the first quarter of 2006."
Earnings in Associated Companies
Earnings in Associated Companies for the fourth quarter of 2005
decreased from the prior year period as a result of the May 2005 sale
of our 50% interest in CYRO Industries to our former partner, Degussa.
Corporate and Unallocated
James P. Cronin, Executive Vice President and Chief Financial
Officer commented, "During the quarter, we recorded a charge of $14.1
million ($10.5 million after tax or $0.22 per diluted share) for
employee-related severance costs principally related to our recently
announced formation of Cytec Specialty Chemicals whereby we combined
our specialty chemicals product lines into one organization under one
leadership team. We anticipate that most of the restructuring related
to this reorganization will be completed in the first half of this
year. In connection with the Surface Specialties acquisition we have
begun projects which are primarily related to the elimination of the
transition service agreements with the former owner for our
information technology hardware infrastructure and incurred
integration costs of $0.2 million."
Interest Expense
Interest expense is significantly higher than the prior year
quarter primarily due to the higher average levels of debt outstanding
resulting from the Surface Specialties acquisition.
Income Tax Expense
Mr. Cronin added, "Our tax provision for the quarter was $2.9
million, or 13.5%, on the earnings before income taxes. Included in
the tax provision is a credit of $2.6 million related to a further
reduction in income tax expense concerning a tax audit in Norway with
respect to prior year's tax returns. Excluding this item, our
underlying effective tax rate for the quarter was 26 %. This compares
to an underlying rate of 25% for the same period of 2004."
Cash Flow
Cash flow provided by operations was $59.0 million for the
quarter. Trade accounts receivable dollars were up sequentially due to
higher sales but days outstanding were essentially flat. Inventory
dollars and days were down slightly as we reduced production at
certain facilities to bring inventories more in line with demand but
this was mostly offset by higher raw material and energy costs.
Capital spending for the quarter was $30 million bringing our full
year total to $105 million.
2006 Outlook
Mr. Lilley commented further, "We expect 2006 to be another
challenging year as we anticipate raw material and energy costs to
remain high but volatile. We have been doing a good job at recovering
the value for our products but the volatility of raw materials and
energy costs also increases the difficulty of passing along spikes in
these costs. On the demand side, our aerospace markets continue to
grow as the build rates for large commercial aircraft, business jets,
military aircraft and commercial rotorcraft continue to increase and
our customers utilize more advanced composites. We are forecasting
weak industrial demand in Cytec Specialty Chemicals in North America
and Europe with the largest impact on our Cytec Surface Specialties
segment and certain of our Cytec Performance Chemicals product lines.
While there were some signs of improvement in the European region in
the fourth quarter of 2005, we remain cautious until we see a more
sustainable improvement in demand. We expect Asia-Pacific and Latin
America to have good growth in 2006. Please note that our reported
results of 2005 include only 10 months of operations from the acquired
Surface Specialties business. Two month pro-forma 2005 sales were $225
million. Our exchange rate assumptions for 2006 include the dollar to
euro rate averaging $1.25.
"Our guidance for the year includes pre-tax incremental
share-based employee compensation expense of approximately $ 10.5
million ($7.7 million after tax or $0.16 per diluted share) which is
the estimated impact of our adopting Statement of Financial Accounting
Standards No. 123(R), "Share Based Payment", (FAS 123R) as of January
1, 2006.
Excluded from our guidance is $4 to $5 million pre-tax for
integration expenses related to the Surface Specialties acquisition.
These integration expenses, the majority of which are duplicative in
nature, are anticipated to be incurred primarily as a result of our
elimination of transition service agreements currently in place with
the former owner regarding the information technology hardware
infrastructure and are expected to be completed in 2006. In addition,
as we continue to identify further benefits of our previously
announced organization consolidation of our specialty chemicals
product lines into Cytec Specialty Chemicals and we expect to announce
further restructuring charges in the first half of the year in the
range of $3 to $5 million. These potential charges are excluded from
our guidance.
"Cytec's specific segment detail for the full year is as follows:
"In Cytec Performance Chemicals, our guidance is for sales to
increase to a range of $900 to $940 million from $856 million with
about a third of the increase due to increased selling prices, about a
quarter related to the additional two months of sales from the
acquired product lines and the remainder due to volume increases. Two
month pro-forma sales in 2005 for the acquired product lines included
in this segment were $20 million. We see continuing strong demand in
our mining chemicals product line and more moderate demand in the
remainder. Operating earnings are expected to increase to a range of
$70 to $75 million due primarily to the higher sales and supported by
continuing manufacturing productivity improvements and good expense
controls. Included in operating earnings is approximately $2.3 million
of incremental share-based compensation expense due to the adoption of
FAS 123R in 2006.
"In Cytec Surface Specialties, our guidance is for sales to
increase to a range of $1.46 to $1.51 billion from $1.24 billion with
about 85% of the increase due to the additional two months of sales
from the acquired product lines and the remainder due to selling price
and modest volume increases. Two month pro-forma sales in 2005 for the
acquired product lines included in this segment were $205 million. We
anticipate continuing weak demand in North America and Europe but we
expect to continue to see good progress in the Asia-Pacific and Latin
American regions and from new global product introductions. Operating
earnings are expected to increase to a range of $85 to $95 million and
this includes approximately $4.5 million of incremental share-based
compensation expense related to FAS 123R. We continue to see many
opportunities to improve our manufacturing and supply chain operations
and with our new organization for Specialty Chemicals in place we
expect the improvement initiatives to continue.
"In Cytec Engineered Materials, our guidance is for sales to
increase to a range of $590 to $620 million from $542 million with
about a quarter of the increase due to increased selling prices and
the remainder due to volume increases. We anticipate increased
aircraft production spurred by the recent orders and the rising
backlog at the large aircraft manufacturers, and continuing
development of new applications for advanced composites. We expect a
continuing high level of investment in our selling, technical and
research and development expenses in light of the continuing
opportunities with aircraft manufacturers as they develop new
platforms for the future. Operating earnings are expected to increase
to a range of $110 to $120 million and includes approximately $2.2
million of incremental share-based compensation expense related to FAS
123R.
"In Building Block Chemicals, our guidance is for sales to
increase to a range of $340 to $355 million of which selling price
increases account for about 40% and the remainder is due to volume
increases. The full year average forecast for the price of propylene
is a range of $0.42-$0.44 per pound and our price for US natural gas
is $9 per MMBTU. Also, we expect a negative impact on Cytec of
approximately $5 million in 2006 due to operating inefficiencies in
the melamine plant as we expect our partner will be taking little, if
any volumes from that plant this year. In 2005, our partner took their
full share of 50% of the plant's output. Including the melamine
impact, operating earnings are expected to be in a range of $17 to 20
million and includes approximately $1.5 million of incremental
share-based compensation expense related to FAS 123R.
"In Corporate and Unallocated, our guidance for 2006 is a loss of
about $7 million which is similar to 2005. Our guidance for other
income(expense), net is expense of about $3 million and our guidance
for equity earnings is about $2 million. Our 2006 guidance for
interest expense, net is a range of $54 to $56 million and our
estimated underlying annual effective tax rate for ongoing operations
is 27%.
In closing Mr. Lilley commented, "Based on all of the above our
forecast of overall annual 2006 sales is now in a range of $3.29 to
$3.42 billion and our forecast for full year diluted earnings per
share is $3.45 to $3.70 an increase of 12% to 20% over 2005's $3.07
per diluted share excluding items as discussed under the full year
results below.
"We begin 2006 cautiously, but with momentum and optimism that by
focusing on what we can control and being flexible to react to rapidly
changing market conditions, we believe we can deliver the highest
performance for all our stakeholders."
Full Year Results
Net earnings for the full year ended December 31, 2005 were $59.1
million, or $1.27 per diluted share on sales of $2,926 million.
Included in the full year ended December 31, 2005 were purchase
accounting related charges of $20.8 million pre-tax (after-tax $15.2
million, or $0.33 per diluted share), related to acquired inventories
from Surface Specialties being recorded at fair value which exceeded
normal manufacturing cost, a charge of $37.0 million or $0.80 per
diluted share related to the write-off of acquired in-process research
and development costs of Surface Specialties, a pre-tax charge of
$44.2 million (after tax $28.1 million or $0.60 per diluted share)
related to currency and interest rate derivative transactions
associated with the Surface Specialties acquisition, a pre-tax charge
of $2.4 million (after tax $1.8 million or $0.04 per diluted share)
related to an anticipated settlement of a certain litigation matter, a
pre-tax charge of $22.0 million (after-tax $14.0 million or $0.30 per
diluted share) related to the optional redemption of our MOPPRS prior
to their maturity, an income tax benefit of $28.3 million, or $0.61
per diluted share, reflecting favorable resolution of tax audits with
respect to prior year tax returns, employee restructuring costs of
$16.8 million (after tax net $12.4 million or $0.27 per diluted
share), integration costs related to the acquired business of pre-tax
$0.2 million (after tax $0.1 million) and a $4.4 million settlement to
resolve a dispute over an environmental matter (after tax $3.2 million
or $0.07 per diluted share). Excluding these items, net earnings were
$142.6 million or $3.07 per diluted share.
Net earnings available to common stockholders for the full year
ended December 31, 2004 were $121.1 million or $2.96 per diluted share
on sales of $1,721 million. Included in full year earnings are the
following special items: a pre-tax charge of $6.1 million ($4.8
million after tax or $0.12 per diluted share) in connection with the
settlement of several environmental and toxic tort lawsuits, a pretax
charge of $8.0 million ($6.2 million after tax or $0.15 per diluted
share) relating to settlements of carbon fiber litigation matters, a
pretax charge of $2.0 million ($1.6 million after tax or $0.04 per
diluted share) relating to the settlement of disputed matters with the
holder of the Company's Series C, a charge to net earnings available
to common stockholders of $9.9 million ($0.24 per diluted share)
related to the redemption of the Company's Series C, a $2.4 million
tax credit, or $0.06 per diluted share, from a favorable outcome of a
completed international tax audit and a net pre-tax gain of $26.8
million ($17.1 million after tax or $0.42 per diluted share)
pertaining to hedging anticipatory transactions related to the then
expected purchase of the Surface Specialties business. Excluding these
items net earnings were $124.1 million or $3.03 per diluted share.
Investor Conference Call to be Held on February 10, 2006 11:00
A.M. ET
Cytec will host their fourth quarter earnings release conference
call on February 10, 2006 at 11:00 a.m. ET. The conference call will
also be simultaneously webcast for all investors from Cytec's website
www.cytec.com. Select the Investor Relations page to access the live
conference call.
A recording of the conference call may be accessed by telephone
from 2:00 p.m. ET on February 10, 2006 until March 3, 2006 at 11:00
p.m. ET by calling 888-203-1112 (U.S.) or 719-457-0820 (International)
and entering access code 2676454. The conference call recording will
also be accessible on Cytec's website for 3 weeks after the conference
call.
Use of Non-GAAP Measures
Management believes that net earnings and diluted earnings per
share before special items, which are non-GAAP measurements, are
meaningful to investors because they provide a view of the Company
with respect to ongoing operating results. Special items represent
significant charges or credits that are important to an understanding
of the Company's overall operating results in the period presented.
Such non-GAAP measurements are not recognized in accordance with
generally accepted accounting principles (GAAP) and should not be
viewed as an alternative to GAAP measures of performance. A
reconciliation of GAAP measurements to non-GAAP can be found at the
end of this release.
Forward-Looking and Cautionary Statements
Except for the historical information and discussions contained
herein, statements contained in this release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Achieving the results
described in these statements involves a number of risks,
uncertainties and other factors that could cause actual results to
differ materially, as discussed in Cytec's filings with the Securities
and Exchange Commission.
Corporate Profile
Cytec Industries Inc. is a global specialty chemicals and
materials company focused on manufacturing and selling value-added
products with pro forma sales in 2005 of approximately $3.2 billion.
Our products serve a diverse range of end markets including aerospace,
adhesives, automotive and industrial coatings, chemical intermediates,
inks, mining, plastics and water treatment. We use our technology and
application development expertise to create chemical and material
solutions that are formulated to perform specific and important
functions in the finished products of our customers.
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Dollars in millions, except per share amounts)
(Unaudited)
Quarter Ended
December 31,
---------------------
2005 2004
---------------------
Net sales $ 787.5 $ 450.6
Manufacturing cost of sales 634.7 349.0
Selling and technical services 57.7 35.9
Research and process development 18.1 10.6
Administrative and general 31.5 15.3
Amortization of acquisition intangibles 8.7 1.5
---------------------
Earnings from operations 36.8 38.3
Other income (expense), net - 29.5
Equity in earnings of associated companies 0.6 2.2
Interest expense, net 16.1 4.4
---------------------
Earnings before income taxes 21.3 65.6
Income tax provision 2.9 19.4
---------------------
Net earnings available to common stockholders $ 18.4 $ 46.2
=====================
Basic earnings per common share:
Net earnings available to common
stockholders $ 0.40 $ 1.16
=====================
Diluted net earnings per common share:
Net earnings available to common
stockholders $ 0.39 $ 1.13
=====================
Dividends per common share $ 0.10 $ 0.10
=====================
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Dollars in millions, except per share amounts)
(Unaudited)
Years ended
---------------------
December 31,
---------------------
2005 2004
---------------------
Net sales $ 2,925.7 $ 1,721.3
Manufacturing cost of sales 2,313.7 1,303.1
Selling and technical services 213.6 139.8
Research and process development 68.5 40.0
Administrative and general 102.1 65.1
Amortization of acquisition intangibles 30.3 5.6
Write-off of acquired in-process research and
development 37.0 -
---------------------
Earnings from operations 160.5 167.7
Other income (expense), net (44.9) 16.9
Equity in earnings of associated companies 7.9 5.2
Interest expense, net 80.0 17.4
---------------------
Earnings from continuing operations before
income taxes 43.5 172.4
Income tax (benefit) provision (14.4) 41.4
---------------------
Earnings from continuing operations 57.9 131.0
Earnings from discontinued operations, net of
taxes 1.2 -
---------------------
Net earnings 59.1 131.0
Premium paid to redeem preferred stock - 9.9
---------------------
Net earnings available to common stockholders $ 59.1 $ 121.1
---------------------
Basic net earnings per common share:
Earnings from continuing operations $ 1.28 $ 3.06
Earnings from discontinued operations, net
of taxes 0.03 -
---------------------
Net earnings available to common
stockholders $ 1.31 $ 3.06
---------------------
Diluted net earnings per common share:
Earnings from continuing operations $ 1.25 $ 2.96
Earnings from discontinued operations, net
of taxes 0.02 -
---------------------
Net earnings available to common
stockholders $ 1.27 $ 2.96
---------------------
Dividends per common share $ 0.40 $ 0.40
---------------------
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED NET SALES AND EARNINGS FROM CONTINUING OPERATIONS BY
BUSINESS SEGMENT
(Millions of dollars)
(Unaudited)
Three Months Ended Twelve Months Ended
December 31, December 31,
---------- ---------- ---------------------
2005 2004 2005 2004
---------- ---------- ---------- ----------
Net sales
- ---------
Cytec Performance
Chemicals
Sales to external
customers $ 220.9 $ 182.9 $ 855.8 $ 712.9
Intersegment sales 1.7 1.6 5.6 4.9
Cytec Surface Specialities 351.0 63.8 1,244.1 260.8
Cytec Engineered Materials 137.1 117.4 541.6 487.0
Building Block Chemicals
Sales to external
customers 78.5 86.5 284.2 260.6
Intersegment sales 25.1 25.4 85.3 85.0
---------- ---------- ---------- ----------
Net sales from segments 814.3 477.6 3,016.6 1,811.2
Elimination of
intersegment revenue (26.8) (27.0) (90.9) (89.9)
---------- ---------- ---------- ----------
Total consolidated net
sales $ 787.5 $ 450.6 $ 2,925.7 $ 1,721.3
- ----------------------------------------------------------------------
% of % of % of % of
sales Sales sales sales
----- ----- ----- -----
Earnings (loss)
from continuing
operations
- ----------------
Cytec Performance
Specialities $ 17.0 8% $19.6 11% $ 56.6 7% $ 57.5 8%
Cytec Surface
Specialities 13.9 4% 5.0 8% 22.0 2% 28.7 11%
Cytec Engineered
Materials 26.7 19% 13.8 12% 103.0 19% 83.4 17%
Building Block
Chemicals (3.9) -4% 3.1 3% 5.7 2% 15.6 5%
------ ----- ------ ------
Earnings from
segments 53.7 7% 41.5 9% 187.3 6% 185.2 10%
Corporate and
Unallocated (16.9) (3.2) (26.8) (17.5)
------ ----- ------ ------
Total consolidated
earnings from
continuing
operations $ 36.8 5% $38.3 8% $160.5 5% $167.7 10%
- ----------------------------------------------------------------------
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in millions, except per share amounts)
(Unaudited
December 31,
---------------------
Assets 2005 2004
---------------------
Current assets
Cash and cash equivalents $ 68.6 $ 323.8
Trade accounts receivable, less allowance
for doubtful accounts of $9.4 and $6.7 in
2005 and 2004, respectively 493.8 248.2
Due from related party 8.0 -
Other accounts receivable 65.9 54.1
Inventories 446.6 263.8
Deferred income taxes 12.2 23.3
Other current assets 27.5 29.3
---------------------
Total current assets 1,122.6 942.5
Investment in associated companies 20.3 85.5
Plants, equipment and facilities, at cost 2,064.3 1,627.2
Less: accumulated depreciation (988.8) (948.6)
---------------------
Net plant investment 1,075.5 678.6
Acquisition intangibles, net of accumulated
amortization of $51.1 and $23.1 in 2005 and
2004, respectively 491.5 66.8
Goodwill 1,012.2 342.4
Deferred income taxes - 54.6
Other assets 88.4 81.2
---------------------
Total assets $ 3,810.5 $ 2,251.6
---------------------
Liabilities
Current liabilities
Accounts payable $ 278.6 $ 138.1
Short-term borrowings 34.3 -
Current maturities of long-term debt 51.2 119.0
Accrued expenses 218.3 178.1
Income taxes payable 43.5 61.5
---------------------
Total current liabilities 625.9 496.7
Long-term debt 1,225.5 300.1
Pension and other postretirement benefit
liabilities 432.5 348.3
Other noncurrent liabilities 224.4 174.5
Deferred income taxes 64.1 -
Stockholders' equity
Preferred stock, 20,000,000 shares authorized;
issued and outstanding 0 shares, Series C
Cumulative, $.01 par value; liquidation value
of $25 per share - -
Common stock, $.01 par value per share,
150,000,000 shares authorized; issued
48,132,640 shares 0.5 0.5
Additional paid-in capital 235.6 122.8
Retained earnings 1,149.7 1,108.5
Accumulated other comprehensive income (loss):
Unearned compensation (2.5) (3.1)
Minimum pension liability (115.6) (108.5)
Unrealized net gains (losses) on cash flow
hedges 0.4 (0.5)
Accumulated translation adjustments 28.2 73.3
---------------------
(89.5) (38.8)
Treasury stock, at cost, 1,833,812 shares in
2005 and 8,297,863 shares in 2004 (58.2) (261.0)
---------------------
Total stockholders' equity 1,238.1 932.0
---------------------
Total liabilities and stockholders' equity $ 3,810.5 $ 2,251.6
---------------------
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in millions)
(Unaudited)
Years ended
---------------------
December 31,
---------------------
2005 2004
---------------------
Cash flows provided by (used in) operating
activities
Earnings from continuing operations $ 57.9 $131.0
Noncash items included in earnings from
continuing operations:
Dividends from associated companies less
than earnings (5.4) (2.6)
Depreciation 110.8 86.6
Amortization 39.0 12.2
Deferred income taxes (25.0) 19.6
Write-off of acquired in-process research
and development 37.0 -
Amortization of write-up to fair value of
finished goods purchased in acquisition 20.8 -
Gains on sale of assets (1.3) -
Unrealized net gains on derivative
instruments - (7.9)
Other 3.0 0.7
Changes in operating assets and liabilities
(excluding effect of acquisitions):
Trade accounts receivable (12.9) (24.1)
Other receivables 31.7 (2.0)
Inventories 9.5 (46.8)
Other assets 21.5 0.4
Accounts payable 2.8 36.5
Accrued expenses (19.3) (7.3)
Income taxes payable (42.6) 7.9
Other liabilities - (36.8)
---------------------
Net cash provided by operating activities of
continuing operations 227.5 167.4
Net cash provided by operating activities of
discontinued operations 4.9 -
---------------------
Net cash provided by operating activities 232.4 167.4
Cash flows provided by (used in) investing
activities
Acquisition of business, net of cash
received (1,459.1) (4.6)
Additions to plants, equipment and
facilities (105.3) (89.3)
Proceeds received on sale of assets 105.3 0.7
Proceeds received on sale of discontinued
business 74.4 -
Minority interests (0.5) -
Advance payment received on land lease - 9.1
---------------------
Net cash used in investing activities (1,385.2) (84.1)
---------------------
Cash flows provided by (used in) financing
activities
Proceeds from long-term debt 1,438.4 -
Payments on long-term debt (571.9) -
Change in short-term borrowings 45.9 (9.3)
Cash dividends (17.8) (15.7)
Proceeds from the exercise of stock options
and warrants 17.7 24.6
Deferred financing cost (5.9) -
Purchase of treasury stock - (13.1)
Redemption of Series C preferred stock - (10.0)
Proceeds from termination of interest rate
swap - 2.9
---------------------
Net cash provided by (used in) financing
activities 906.4 (20.6)
---------------------
Effect of currency rate changes on cash and cash
equivalents (8.8) 10.0
Increase (decrease) in cash and cash equivalents (255.2) 72.7
Cash and cash equivalents, beginning of year 323.8 251.1
---------------------
Cash and cash equivalents, end of year $ 68.6 $323.8
---------------------
Cytec Industries Inc.
Reconciliation of GAAP and Non-GAAP Measures
Management believes that net earnings and diluted earnings per share
before special items, which are non-GAAP measurements, are meaningful
to investors because they provide a view of the Company with respect
to ongoing operating results. Special items represent significant
charges or credits that are important to an understanding of the
Company's overall operating results in the periods presented. Such
non-GAAP measurements are not recognized in accordance with generally
accepted accounting principles (GAAP) and should not be viewed as an
alternative to GAAP measures of performance.
Three Months Ended December 31, 2005
Net Diluted
Earnings EPS
---------- ----------
GAAP Net Earnings available to common
shareholders $ 18.4 $ 0.39
- Income tax benefit reflecting further partial
resolution of a tax audit on Norway with
respect to prior year tax
returns (2.6) (0.05)
- Restructuring charge (after tax) 10.5 0.22
- Integration expenses related to acquired
businesses (after tax) 0.1 0.0
---------- ----------
Non-GAAP Net Earnings available to common
shareholders $ 26.4 $ 0.56
========== ==========
Twelve months Ended December 31, 2005
Net Diluted
Earnings EPS
---------- ----------
GAAP Net Earnings available to common
shareholders $ 59.1 $ 1.27
- Purchase accounting charges for fair value of
inventory in excess of normal manufacturing
cost (after tax) 15.2 0.33
- Write-off of in-process research and
development costs of Surface Specialties 37.0 0.80
- Loss on currency and interest rate derivative
transactions (after tax) 28.1 0.60
- Anticipated settlement of a certain
litigation matter (after tax) 1.8 0.04
- Optional redemption of Mandatory Par Put
Remarketed Securities (MOPPRS) prior to their
maturity (after
tax) 14.0 0.30
- Income tax benefit reflecting favorable
developments on of tax audits with respect to
prior years returns (28.3) (0.61)
- Restructuring costs (after tax) 12.4 0.27
- Settlement to resolve a dispute over an
environmental matter (after tax) 3.2 0.07
- Integration expenses related to acquired
businesses (after tax) 0.1 0.0
---------- ----------
Non-GAAP Net Earnings available to common
shareholders $ 142.6 $ 3.07
========== ==========
Three Months Ended December 31, 2004
Net Diluted
Earnings EPS
---------- ----------
GAAP Net Earnings available to common
shareholders $ 46.2 $ 1.13
- Gain on currency and interest rate
derivative transactions (after tax) (17.1) (0.42)
---------- ----------
Non-GAAP Net Earnings available to common
shareholders $ 29.1 $ 0.71
========== ==========
Twelve months Ended December 31, 2004
Net Diluted
Earnings EPS
---------- ----------
GAAP Net Earnings available to common
shareholders $ 121.1 $ 2.96
- Litigation settlement of environmental and
toxic tort lawsuits (after tax) 4.8 0.12
- Settlement of carbon fiber litigation matter
(after tax) 6.2 0.15
- Settlement of disputed matters with Series C
holders (after tax) 1.6 0.04
- Premium paid to redeem Series C 9.9 0.24
- Tax benefit related to international tax
audit (2.4) (0.06)
- Gain on currency and interest rate derivative
transactions (after tax) (17.1) (0.42)
--------- ---------
Non-GAAP Net Earnings available to common
shareholders $ 124.1 $ 3.03
========= =========
CONTACT: Cytec Industries Inc.
Investment Community:
David M. Drillock, 973-357-3249
or
Media:
Gail Petersen, 973-357-3319